Fatty acids, inhibitors for the DNA binding of c-Myc/Max dimer, suppress proliferation and induce apoptosis of differentiated HL-60 human leukemia cell

Leukemia

Volumn 20, Issue 1, 2006, Pages 122-127

  Jung, K C ^a   Park, C H ^a   Hwang, Y H ^a   Rhee, H S ^a   Lee, J H ^a   Kim, H K ^a   Yang, Chul H ^a  

^a Seoul National University   (South Korea)

Author keywords

Apoptosis; c Myc; Fatty acid; HL 60; Proliferation; Transcription factor

Indexed keywords

ARACHIDONIC ACID; FATTY ACID; LINOLENIC ACID; MAX PROTEIN; MYC PROTEIN; MYRISTIC ACID; STEARIC ACID; UNSATURATED FATTY ACID;

APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRAIN HL 60; CONTROLLED STUDY; DIMERIZATION; DNA BINDING; DNA SEQUENCE; DOWN REGULATION; DRUG MECHANISM; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; IC 50; LEUKEMIA CELL; PRIORITY JOURNAL; PROTEIN DOMAIN; SEQUENCE ANALYSIS;

EID: 33644980674     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/sj.leu.2404022     Document Type: Article

References (28)

1. Henriksson M, Luscher B. Proteins of the Myc network: Essential regulators of cell growth and differentiation. Adv Cancer Res 1996; 68: 109-182.
2. Facchini LM, Penn LZ. The molecular role of Myc in growth and transformation: Recent discoveries lead to new insights. FASEB J 1998; 12: 633-651.
3. Prendergast GC. Mechanisms of apoptosis by c-Myc. Oncogene 1999; 18: 2967-2987.
4. Iritani BM, Eisenman RN. c-Myc enhances protein synthesis and cell size during B lymphocyte development. Proc Natl Acad Sci USA 1999; 96: 13180-13185.
5. Blackwood EM, Eisenman RN. Max: A helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. Science 1991; 251: 1211-1217.
6. Prendergast GC, Lawe D, Ziff EB. Association of Myn, the murine homolog of max, with c-Myc stimulates methylation-sensitive DNA binding and ras cotransformation. Cell 1991; 65: 395-407.
7. Blackwood EM, Luscher B, Eisenman RN. Myc and Max associate in vivo. Genes Dev 1992; 6: 71-80.
8. Wenzel A, Cziepluch C, Hamann U, Schurmann J, Schwab M. The N-Myc oncoprotein is associated in vivo with the phosphoprotein Max(p20/22) in human neuroblastoma cells. EMBO J 1991; 10: 3703-3712.
9. Blackwell TK, Kretzner L, Blackwood EM, Eisenman RN, Weintraub H. Sequence-specific DNA binding by the c-Myc protein. Science 1990; 250: 1149-1151.
10. Kerkhoff E, Bister K, Klempnauer KH. Sequence-specific DNA binding by Myc proteins. Proc Natl Acad Sci USA 1991; 88: 4323-4327.
11. Dang CV, Resar LM, Emison E, Kim S, Li Q, Prescott JE et al. Function of the c-Myc oncogenic transcription factor. Exp Cell Res 1999; 253: 63-77.
12. Amati B, Littlewood TD, Evan GI, Land H. The c-Myc protein induces cell cycle progression and apoptosis through dimerization with Max. EMBO J 1993; 12: 5083-5087.
13. Guerin M, Barrois M, Terrier MJ, Spielmann M, Riou G. Overexpression of either c-myc or c-erbB-2/neu proto-oncogenes in human breast carcinomas: correlation with poor prognosis. Oncogene Res 1988; 3: 21-31.
14. Mariani-Costantini R, Escot C, Theillet C, Gentile A, Merlo G, Lidereau R et al. In situ c-myc expression and genomic status of the c-myc locus in infiltrating ductal carcinomas of the breast. Cancer Res 1988; 48: 199-205.
15. Spandidos DA, Field JK, Agnantis NJ, Evan GI, Moore JP. High levels of c-myc protein in human breast tumours determined by a sensitive ELISA technique. Anticancer Res 1989; 9: 821-826.
16. Rabbitts TH, Hamlyn PH, Baer R. Altered nucleotide sequences of a translocated c-myc gene in Burkitt lymphoma. Nature 1983; 306: 760-765.
17. Nesbit CE, Tersak JM, Prochownik EV. MYC oncogenes and human neoplastic disease. Oncogene 1999; 18: 3004-3016.
18. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995; 267: 1456-1462.
19. Kinloch RA, Treherne JM, Furness LM, Hajimohamadreza I. The pharmacology of apoptosis. Trends Pharmacol Sci 1999; 20: 35-42.
20. Dirsch VM, Antlsperger DS, Hentze H, Vollmar AM. Ajoene, an experimental anti-leukemic drug: Mechanism of cell death. Leukemia 2002; 16: 74-83.
21. Gamet-Payrastre L, Li P, Lumeau S, Cassar G, Dupont MA, Chevolleau S et al. Sulforaphane, a naturally occurring isothiocyanate, induces cell cycle arrest and apoptosis in HT29 human colon cancer cells. Cancer Res 2000; 60: 1426-1433.
22. Klucar J, Al-Rubeai M. G2 cell cycle arrest and apoptosis are induced in Burkitt's lymphoma cells by the anticancer agent oracin. FEES Lett 1997; 400: 127-130.
23. Bieker R, Lerchenmuller C, Wehmeyer J, Serve HL, Mesters RM, Buchner T et al. Phase I study of liposomal daunorubicin in relapsed and refractory acute myeloid leukemia. Oncol Rep 2003; 10: 915-920.
24. Jung KC, Rhee HS, Park CH, Yang CH. Determination of the dissociation constants for recombinant c-Myc, Max, and DNA complexes: The inhibitory effect of linoleic acid on the DNA-binding step. Biochem Biophys Res Commun 2005; 334: 269-275.
25. Collins SJ, Ruscetti FW, Gallagher RE, Gallo RC. Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds. Proc Natl Acad Sci USA 1978; 75: 2458-2462.
26. Gillis RC, Daley BJ, Enderson BL, Karlstad MD. Inhibition of 5-lipoxygenase induces cell death in anti-inflammatory fatty acid-treated HL-60 cells. JPEN J Parenter Enteral Nutr 2004; 28: 308-314.
27. Liu Y, Levy R. Phospholipase A2 has a role in proliferation but not in differentiation of HL-60 cells. Biochim Biophys Acta 1997; 1355: 270-280.
28. Gillis RC, Daley BJ, Enderson BL, Karlstad MD. Eicosapentaenoic acid and gamma-linolenic acid induce apoptosis in HL-60 cells. J Surg Res 2002; 107: 145-153.